Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
about
Multiple Origins of the Pathogenic Yeast Candida orthopsilosis by Separate Hybridizations between Two Parental SpeciesResistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible IsolatesMolecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study.Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China.Novel Polymorphic Multilocus Microsatellite Markers to Distinguish Candida tropicalis Isolates.Identification and Antifungal Susceptibility Profile of Candida guilliermondii and Candida fermentati from a Multicenter Study in China.In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen.Notable Increasing Trend in Azole Non-susceptible Candida tropicalis Causing Invasive Candidiasis in China (August 2009 to July 2014): Molecular Epidemiology and Clinical Azole Consumption.Population structure and molecular genetic characterization of clinical Candida tropicalis isolates from a tertiary-care hospital in Kuwait reveal infections with unique strains.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.Changing epidemiology of candidaemia in Australia.Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Antifungal susceptibility of Candida species isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints.The Regulatory Pathway for Antifungal Drugs: A US Perspective.Antifungal resistance: current trends and future strategies to combat.Species distribution, virulence factors, and antifungal susceptibility among Candida parapsilosis complex isolates from clinical specimens at Siriraj Hospital, Thailand, from 2011 to 2015.Hybridization and emergence of virulence in opportunistic human yeast pathogens.Cost-effectiveness of de-escalation from micafungin versus escalation from fluconazole for invasive candidiasis in China.Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms.Novel fluconazole derivatives with promising antifungal activity.Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibilityEpidemiological investigation of non-albicans Candida species recovered from mycotic mastitis of cows in Yinchuan, Ningxia of ChinaSusceptibility Testing of Fungi to Antifungal Drugs
P2860
Q28822331-3EDB0E92-8E26-496A-969C-F3C92BE05056Q28833536-09521473-2839-43DE-A433-8BEB8998339DQ33715460-C0F74AA4-36E9-49B9-804B-6FD8D66BE0F2Q35746090-B93BBCA7-E887-4B5C-86E0-DDAF1C9878DEQ36106409-84CA3B8D-D560-40F1-97A4-35A6BF740B66Q36184407-04135274-3199-4F37-9853-FED7A651AEA6Q37132105-A12885AA-59D7-46A9-A89F-782BA2FF0324Q37160845-C64F4A6D-3A44-43F8-998F-A44BB063CC67Q37714473-8CC5171D-0C6F-440B-A5E9-D19DBB88BB42Q38602218-DA4D778D-B3E0-4B22-B091-99FD8657F63AQ38610744-4BF88F74-2702-4CCD-AC0E-457B68D0E3E0Q38803537-41D6428B-A0F9-4E4D-B1B6-FA69F7F57ACEQ38863487-B6EAA58C-EE8A-4709-871C-81128E7C41E3Q40118569-8144796B-BEB9-4CDE-A286-63B21556B34FQ40169961-AFFB8D82-49D7-49F7-B260-E7737D8E0896Q40542769-CEAF91CA-2403-43CB-B5EC-150FDE96122EQ40910106-39E8982E-155A-4E4C-960B-53B73A42C9ECQ41632930-6140046D-826C-46EB-B057-9DDC2A828551Q46290886-29A1F53A-1E98-43F2-A7F8-C6A6B2096674Q46339999-52058012-A0E1-4262-91F3-E59295321EFCQ47206195-997A882F-7867-46F2-AAFD-8A33BB236F35Q49199427-0E82F02D-B629-45C1-AF08-615713822A1BQ49569154-24196DA1-F64D-4986-80B2-B09B1665F508Q52629707-8C8D6B6D-0643-4C42-9E0B-CE793DA2EEB5Q57817175-1438CCC2-1BBD-4A61-9429-416763042655Q58696409-A4985AB3-E5B7-4D90-B24D-7FBE7873AC6EQ58737037-34546E6F-D5AE-483F-89B9-A1551669C6C7
P2860
Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antifungal susceptibilities of ...... 3 year national surveillance.
@ast
Antifungal susceptibilities of ...... 3 year national surveillance.
@en
type
label
Antifungal susceptibilities of ...... 3 year national surveillance.
@ast
Antifungal susceptibilities of ...... 3 year national surveillance.
@en
prefLabel
Antifungal susceptibilities of ...... 3 year national surveillance.
@ast
Antifungal susceptibilities of ...... 3 year national surveillance.
@en
P2093
P2860
P921
P356
P1476
Antifungal susceptibilities of ...... 3 year national surveillance.
@en
P2093
Fanrong Kong
Gui-Ling Zou
Sharon C-A Chen
Shu-Lan Chen
Tie-Shi Hu
P2860
P304
P356
10.1093/JAC/DKU460
P407
P577
2014-12-03T00:00:00Z